Evidence map›Paper›PMID 24367261›Full record

ArticlePLoS pathogens2013

Toxoplasma gondii-induced activation of EGFR prevents autophagy protein-mediated killing of the parasite.

Luis Muniz-Feliciano, Jennifer Van Grol, Jose-Andres C Portillo, Lloyd Liew, Bing Liu, Cathleen R Carlin, Vern B Carruthers, Stephen Matthews, Carlos S Subauste

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. HarnessingAnnals of medicine · 2026
    Review
  3. A novel anti-Microbiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Receptor Tyrosine Kinase Signaling InvolvesTropical medicine and infectious disease · 2024
    Review
  9. Article
  10. Article
  11. Susceptibility ofmBio · 2024
    Article
  12. Article
  13. p97/VCP targetsmSphere · 2023
    Article
  14. Review
  15. mBio · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Early immune and host cell responses toFrontiers in parasitology · 2023
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Luis Muniz-FelicianoDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America ; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Jennifer Van GrolDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America ; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Jose-Andres C PortilloDivision of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Lloyd LiewDivision of Molecular Biosciences, Imperial College London, London, United Kingdom.
Bing LiuDivision of Molecular Biosciences, Imperial College London, London, United Kingdom.
Cathleen R CarlinDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Vern B CarruthersDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Stephen MatthewsDivision of Molecular Biosciences, Imperial College London, London, United Kingdom.
Carlos S SubausteDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, United States of America ; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America ; Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.
Case Western Reserve University · USImperial College London · GBMichigan United · USUniversity School · US

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
MICRONEME FUNCTION IN TOXOPLASMAR01AI046675 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 2000 to 2021
$6.5M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
Autophagy and Ocular ToxoplasmosisR01EY018341 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI SUBAUSTE, CARLOS S · 2009 to 2024
$5.0M
Immunology Training Program-PredoctoralT32AI089474 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI COBB, BRIAN A · 2010 to 2025
$3.4M
Modulation of Rab7-Dependent Degradative Pathways by Novel Adenovirus ProteinR01GM081498 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CARLIN, CATHLEEN R · 2009 to 2012
$1.3M
Biotechnology and Biological Sciences Research Council BB/E02520X/1Medical Research Council G0800038Medical Research Council MR/J006874/1NEI NIH HHS EY018341NEI NIH HHS P30 EY011373NEI NIH HHS P30 EY11373NEI NIH HHS R01 EY018341NEI NIH HHS T32 EY007157NIAID NIH HHS R01 AI046675NIAID NIH HHS T32 AI089474NIAID NIH HHS T32-AI089474NIGMS NIH HHS GM081498NIGMS NIH HHS R01 GM081498
6 · The paper itself

Abstract

Toxoplasma gondii resides in an intracellular compartment (parasitophorous vacuole) that excludes transmembrane molecules required for endosome-lysosome recruitment. Thus, the parasite survives by avoiding lysosomal degradation. However, autophagy can re-route the parasitophorous vacuole to the lysosomes and cause parasite killing. This raises the possibility that T. gondii may deploy a strategy to prevent autophagic targeting to maintain the non-fusogenic nature of the vacuole. We report that T. gondii activated EGFR in endothelial cells, retinal pigment epithelial cells and microglia. Blockade of EGFR or its downstream molecule, Akt, caused targeting of the parasite by LC3(+) structures, vacuole-lysosomal fusion, lysosomal degradation and killing of the parasite that were dependent on the autophagy proteins Atg7 and Beclin 1. Disassembly of GPCR or inhibition of metalloproteinases did not prevent EGFR-Akt activation. T. gondii micronemal proteins (MICs) containing EGF domains (EGF-MICs; MIC3 and MIC6) appeared to promote EGFR activation. Parasites defective in EGF-MICs (MIC1 ko, deficient in MIC1 and secretion of MIC6; MIC3 ko, deficient in MIC3; and MIC1-3 ko, deficient in MIC1, MIC3 and secretion of MIC6) caused impaired EGFR-Akt activation and recombinant EGF-MICs (MIC3 and MIC6) caused EGFR-Akt activation. In cells treated with autophagy stimulators (CD154, rapamycin) EGFR signaling inhibited LC3 accumulation around the parasite. Moreover, increased LC3 accumulation and parasite killing were noted in CD154-activated cells infected with MIC1-3 ko parasites. Finally, recombinant MIC3 and MIC6 inhibited parasite killing triggered by CD154 particularly against MIC1-3 ko parasites. Thus, our findings identified EGFR activation as a strategy used by T. gondii to maintain the non-fusogenic nature of the parasitophorous vacuole and suggest that EGF-MICs have a novel role in affecting signaling in host cells to promote parasite survival.

Indexed as

AnimalsApoptosis Regulatory ProteinsAutophagyAutophagy-Related Protein 7Beclin-1Cells, CulturedCHO CellsCricetinaeCricetulusEnzyme ActivationErbB ReceptorsHumansMembrane ProteinsMiceOncogene Protein v-aktToxoplasmaApoptosis Regulatory ProteinsATG7 protein, humanAutophagy-Related Protein 7Beclin-1BECN1 protein, humanEGFR protein, humanErbB ReceptorsMembrane ProteinsOncogene Protein v-aktUbiquitin-Activating Enzymes

Identifiers

PMID24367261
PMCPMC3868508
OpenAlexW2064760916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.